
|Articles|November 28, 2011
Mark Zitter Addresses How Oncology Payers Are Becoming Stricter About Covered Therapies
Advertisement
Mark Zitter, Founder and CEO of The Zitter Group, in San Francisco and Millburn, NJ, discusses how oncology payers are tightening the reins with approval requirements and the delicacy involved in revising guidelines around cancer care.
Mr. Zitter talks about several of the payers' changes, which include prior authorizations, clinical guidelines, and decision-support programs. He also addresses the ongoing friction between payers and providers and how critical it is to find resolution.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
3
ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
4
Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization
5








































